Analytical Data
-
基因名
MIg
- Application
-
别名
MIg；MIG6；ERBB receptor feedback inhibitor 1
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P83881
-
表达区间
1-106aa
-
氨基酸序列
MVNVPKTRRT FCKKCGKHQP HKVTQYKKGK DSLYAQGKRR YDRKQSGYGG QTKPIFRKKA KTTKKIVLRL ECVEPNCRSK RMLAIKRCKH FELGGDKKRK GQVIQF
-
分子量
12.4 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of MIg recombinant proteins stems from the growing need to understand and manipulate immune responses for therapeutic purposes. MIg, or "Monoclonal Immunoglobulin," plays a critical role in both the innate and adaptive immune systems, facilitating recognition and neutralization of pathogens. Recent advancements in biotechnology have enabled the production of MIg as recombinant proteins, allowing researchers to investigate their structure, function, and potential applications in immunotherapy and vaccine development. The ability to produce MIg in a controlled environment not only enhances our understanding of immune mechanisms but also paves the way for developing novel treatments for autoimmune diseases, cancers, and infectious diseases. As the field of immunology continues to evolve, the exploration of MIg recombinant proteins becomes increasingly significant, with potential implications for improving patient outcomes through targeted therapies and personalized medicine approaches. This research not only contributes to basic scientific knowledge but also holds promise for transformative healthcare solutions.
